Bleakley Financial Group »

Janux Therapeutics shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $265k 19k 13.90

More positions owned by Bleakley Financial Group

Ishares Tr Core S&p500 Etf (IVV)
Sprott Asset Management Physical Gold An (CEF)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Global X Fds 1-3 Month T-bill (CLIP)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)

View all positions for Bleakley Financial Group

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Henderson Group
State Street Corporation
FMR
Vanguard Group
Prosight Management
Vanguard Capital Management
TCG Crossover Management
Wellington Management Company
Alyeska Investment Group
Vanguard Portfolio Management
Deep Track Capital
Point72 Asset Management
Geode Capital Management

View all funds holding Janux Therapeutics